Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-02-03 11:23 Tx date 2022-07-05 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Holder: The Estate of Walter Broad (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+25,000 vol $0.04 each |
984,000 | |
Filed 2023-02-03 11:21 Tx date 2022-05-25 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,575
+35,000 vol $0.045 each |
776,000 | |
Filed 2023-02-03 11:20 Tx date 2022-10-17 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-100.00
-5,000 vol $0.02 each |
2,025,500 | |
Filed 2023-02-03 11:18 Tx date 2022-10-13 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-860.00
-43,000 vol $0.02 each |
2,030,500 | |
Filed 2023-02-03 11:18 Tx date 2022-09-28 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-500.00
-25,000 vol $0.02 each |
2,073,500 | |
Filed 2023-02-03 11:16 Tx date 2022-08-19 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-600.00
-30,000 vol $0.02 each |
2,098,500 | |
Filed 2023-02-03 11:15 Tx date 2022-08-04 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,920
-146,000 vol $0.02 each |
2,128,500 | |
Filed 2023-02-03 11:14 Tx date 2022-07-26 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,400
-56,000 vol $0.025 each |
2,274,500 | |
Filed 2023-02-03 11:13 Tx date 2022-07-25 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-360.00
-12,000 vol $0.03 each |
2,330,500 | |
Filed 2023-02-03 11:12 Tx date 2022-07-22 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,050
-35,000 vol $0.03 each |
2,342,500 | |
Filed 2023-02-03 11:11 Tx date 2022-07-20 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30.00
-1,000 vol $0.03 each |
2,377,500 | |
Filed 2023-02-03 11:10 Tx date 2022-07-11 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,360
-96,000 vol $0.035 each |
2,378,500 | |
Filed 2023-02-03 11:09 Tx date 2022-06-21 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,080
+24,000 vol $0.045 each |
2,474,500 | |
Filed 2023-02-03 11:08 Tx date 2022-06-16 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,925
+65,000 vol $0.045 each |
2,450,500 | |
Filed 2023-02-03 11:07 Tx date 2022-06-15 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
2,385,500 | |
Filed 2023-02-03 11:06 Tx date 2022-06-13 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+100,000 vol $0.045 each |
2,365,500 | |
Filed 2023-02-03 11:05 Tx date 2022-06-10 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45.00
+1,000 vol $0.045 each |
2,265,500 | |
Filed 2023-02-03 11:04 Tx date 2022-06-09 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$675.00
+15,000 vol $0.045 each |
2,264,500 | |
Filed 2023-02-03 11:04 Tx date 2022-06-08 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,480
+87,000 vol $0.04 each |
2,249,500 | |
Filed 2023-02-03 11:02 Tx date 2022-06-01 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,890
+42,000 vol $0.045 each |
2,162,500 | |
Filed 2023-02-03 11:01 Tx date 2022-05-27 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,105
+69,000 vol $0.045 each |
2,120,500 | |
Filed 2023-02-03 11:00 Tx date 2022-05-26 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,665
+37,000 vol $0.045 each |
2,051,500 | |
Filed 2023-02-03 10:59 Tx date 2022-05-25 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,960
+99,000 vol $0.04 each |
2,014,500 | |
Filed 2023-02-03 10:58 Tx date 2022-05-20 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$270.00
+6,000 vol $0.045 each |
1,915,500 | |
Filed 2023-02-03 10:57 Tx date 2022-05-12 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+28,000 vol $0.04 each |
1,909,500 | |
Filed 2023-02-03 10:52 Tx date 2022-05-11 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Holder: The Estate of Walter Broad (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
959,000 | ||
Filed 2023-02-03 10:50 Tx date 2022-05-11 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
741,000 | ||
Filed 2023-02-03 10:48 Tx date 2022-05-11 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
Filed 2023-02-03 10:46 Tx date 2022-05-11 |
$PAS
Pascal Biosciences Inc. |
McDermid, Elaine Catherine
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,881,500 | ||
Filed 2022-07-15 17:58 Tx date 2013-06-01 |
$PAS
bioMmune Technologies Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-15 17:58 Tx date 2013-06-01 |
$PAS
bioMmune Technologies Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2013-05-28 17:05 Tx date 2013-05-24 |
$PAS
bioMmune Technologies Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2013-05-28 17:04 Tx date 2013-05-24 |
$PAS
bioMmune Technologies Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-04 18:32 Tx date 2022-02-28 |
$PAS
Pascal Biosciences Inc. |
Bapty, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2022-03-04 18:29 Tx date 2022-03-01 |
$PAS
Pascal Biosciences Inc. |
Bapty, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-14 09:25 Tx date 2021-06-02 |
$PAS
Pascal Biosciences Inc. |
van der Horst, Mark Adrian
5 - Senior Officer of Issuer
Holder: Gale Capital Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
195,000 | ||
Filed 2020-12-14 22:09 Tx date 2020-11-30 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$168,595
+842,975 vol $0.20 each |
1,368,262 | |
Filed 2020-12-14 22:07 Tx date 2020-11-30 |
$PAS
Pascal Biosciences Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$62,170
+310,850 vol $0.20 each |
980,849 | |
Filed 2018-12-13 Tx date 2018-11-23 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-290,692 vol |
||
Filed 2018-12-13 Tx date 2018-11-23 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-290,692 vol |
525,287 | |
Filed 2018-12-12 Tx date 2018-11-23 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-290,692 vol |
525,287 | |
Filed 2018-10-03 Tx date 2018-10-03 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+20,000 vol |
103,000 | |
Filed 2018-09-27 Tx date 2018-09-21 |
$PAS
Pascal Biosciences Inc. |
Nikolich, Karoly
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,000
+150,000 vol $0.20 each |
316,666 | |
Filed 2018-09-27 Tx date 2018-09-21 |
$PAS
Pascal Biosciences Inc. |
Nikolich, Karoly
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
352,500 | |
Filed 2018-09-17 Tx date 2018-09-14 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,000 vol |
58,000 | |
Filed 2018-09-17 Tx date 2018-09-17 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+25,000 vol |
83,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
572,500 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
425,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Nikolich, Karoly
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
502,500 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+375,000 vol |
842,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Gadek, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
550,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Eastland, Julie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+375,000 vol |
375,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
225,000 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
Bell, Graeme
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
Filed 2018-07-26 Tx date 2018-07-16 |
$PAS
Pascal Biosciences Inc. |
Eastland, Julie
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-07-26 Tx date 2018-07-16 |
$PAS
Pascal Biosciences Inc. |
Eastland, Julie
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-22 Tx date 2018-06-18 |
$PAS
Pascal Biosciences Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-175,000 vol |
125,000 | |
Filed 2018-06-22 Tx date 2018-06-18 |
$PAS
Pascal Biosciences Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+175,000 vol |
175,000 | |
Filed 2018-06-04 Tx date 2018-05-18 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-161,718 vol |
392,543 | |
Filed 2018-06-04 Tx date 2018-05-18 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+161,718 vol |
815,979 | |
Filed 2018-03-16 Tx date 2018-03-12 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+387,594 vol |
554,261 | |
Filed 2018-03-16 Tx date 2018-03-12 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+387,594 vol |
654,261 | |
Filed 2018-02-02 Tx date 2018-01-29 |
$PAS
Pascal Biosciences Inc. |
Gadek, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
Filed 2018-02-02 Tx date 2017-12-05 |
$PAS
Pascal Biosciences Inc. |
Bell, Graeme
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-02 Tx date 2017-12-05 |
$PAS
Pascal Biosciences Inc. |
Bell, Graeme
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-02 Tx date 2018-01-29 |
$PAS
Pascal Biosciences Inc. |
Bell, Graeme
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2017-11-27 Tx date 2016-04-13 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,320
+14,000 vol $0.38 each |
33,000 | |
Filed 2017-11-27 Tx date 2014-02-19 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,320
+19,000 vol $0.28 each |
19,000 | |
Filed 2017-11-15 Tx date 2017-11-15 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
20,000 | |
Filed 2017-11-15 Tx date 2017-11-14 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
10,000 | |
Filed 2017-07-14 Tx date 2017-07-10 |
$PAS
Pascal Biosciences Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+100,000 vol |
266,667 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$PAS
Pascal Biosciences Inc. |
Gadek, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
300,000 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$PAS
Pascal Biosciences Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,000 vol |
300,000 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$PAS
Pascal Biosciences Inc. |
Nikolich, Karoly
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
402,500 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$PAS
Pascal Biosciences Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
300,000 |